Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database.
- Published in:
- Drug Safety, 2021, v. 44, n. 7, p. 787, doi. 10.1007/s40264-021-01077-9
- By:
- Publication type:
- Article
Works matching AU Vabre, Clémentine
Results: 5
1
2
Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories—A French population‐based study using the French national health data system.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E307, doi. 10.1002/ajh.26621
- By:
- Publication type:
- Article
3
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 4, p. 1338, doi. 10.1111/bcp.15576
- By:
- Publication type:
- Article
4
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 3, p. 383, doi. 10.1007/s00228-022-03440-w
- By:
- Publication type:
- Article
5
What changes in prescription patterns of antiemetic medications in pregnant women in France?
- Published in:
- Fundamental & Clinical Pharmacology, 2021, v. 35, n. 6, p. 1159, doi. 10.1111/fcp.12681
- By:
- Publication type:
- Article